ABSTRACT
El leiomiosarcoma primario de la glándula adrenal es un tumor maligno infrecuente,con escasos reportes en la literatura internacional. Presentamos el caso de una paciente de 50 años con un tumor en la glándula adrenal derecha, diagnosticado mediante un examen ultrasonográfico de rutina y confirmado por tomografía computada y resonancia magnética. Se realizó una adrenalectomía derecha, y el estudio anatomopatológico reportó un leiomiosarcoma adrenal primario. Este tumor primario de la glándula adrenal es una entidad maligna muy rara, clínicamente silente o con síntomas inespecíficos. A menudo se detecta a través de estudios por imágenes como una masa de gran tamaño, pero su diagnóstico definitivo es histopatológico con técnicas de inmunohistoquímica.
Abstract Primary leiomyosarcoma of the adrenal glandis a rare malignant tumor. Few reports aredescribed in the international literature. We report the case of a 50 year old patient, who was diagnosed with a tumor in the right adrenal gland by ultrasonographic examination routine, also confirmed by computed tomography (CT) and magnetic resonance imaging (MRI). Right adrenalectomy was performed. Pathological study reported primary adrenal leiomyosarcoma.This primary malignant tumor of the adrenal gland is a very rare, clinically silent mass or with nonspecific symptoms, often detectable by imaging studies as large masses, but definitive diagnosis is made by immunohistochemistry.
Subject(s)
Adult , Female , Adrenal Glands , Leiomyosarcoma , General Surgery , Magnetic Resonance Imaging , Neoplasms , Pain , Ultrasonic TherapyABSTRACT
El leiomiosarcoma primario de la glándula adrenal es un tumor maligno infrecuente, con escasos reportes en la literatura internacional. Presentamos el caso de una paciente de 50 años con un tumor en la glándula adrenal derecha, diagnosticado mediante un examen ultrasonográfico de rutina y confirmado por tomografía computada y resonancia magnética. Se realizó una adrenalectomía derecha, y el estudio anatomopatológico reportó un leiomiosarcoma adrenal primario. Este tumor primario de la glándula adrenal es una entidad maligna muy rara, clínicamente silente o con síntomas inespecíficos. A menudo se detecta a través de estudios por imágenes como una masa de gran tamaño, pero su diagnóstico definitivo es histopatológico con técnicas de inmunohistoquímica.(AU)
Abstract Primary leiomyosarcoma of the adrenal glandis a rare malignant tumor. Few reports aredescribed in the international literature. We report the case of a 50 year old patient, who was diagnosed with a tumor in the right adrenal gland by ultrasonographic examination routine, also confirmed by computed tomography (CT) and magnetic resonance imaging (MRI). Right adrenalectomy was performed. Pathological study reported primary adrenal leiomyosarcoma. This primary malignant tumor of the adrenal gland is a very rare, clinically silent mass or with nonspecific symptoms, often detectable by imaging studies as large masses, but definitive diagnosis is made by immunohistochemistry.(AU)
ABSTRACT
The bronchial tree represents the most frequent site of origin of carcinoids (around 25% of the total). The spectrum of differentiation of lung neuroendocrine tumors ranges from low-malignancy (carcinoids) to highly aggressive forms (small cell lung carcinoma) Diagnostic and therapeutic strategies therefore vary greatly. In well differentiated tumors (carcinoids) signs and symptoms are related to the airways obstruction in central forms, while peripheral forms are mostly discovered accidentally if asymptomatic. Clinical or subclinical paraneoplastic syndromes are associated in a minority of cases. Diagnostic work-up includes CT multislice, bronchial endoscopy and Octreoscan with chest Single Photon Emission Computed Tomography (SPECT). Further contribute may be added by the (68), Ga-DOTA-D-Phe(1)-Tyr(3)-ocreotide (DOTATOC) and 5-hydroxytryptophan (5-HTP) PET-CT, at present available only in a few centres, and by endobronchial ultrasound (EBUS), fluorescence bronchoscopy and virtual bronchoscopy. Surgery is the treatment of choice, while medical therapy is useful to treat the hypersecretion in paraneoplastic syndromes and to control tumor proliferation in metastatic or/and inoperable disease.
